What a sad for the tenured folks at Cordis who will end up retiring instead of fighting Cardinal on sales strategy. We were fed the Credo and even though we were warned, JNJ destroyed another device company that had so much promise. Cardinal is not a bad company, but they aren't interested in developing cutting edge products so my decision is made.
Now that is some funny stuff.
For those keeping track of the relationships between the pharmaceutical industry and former FDA staffers, Johnson & Johnson added Mark McClellan, who served as FDA commissioner from 2002 to 2004 and then headed the Centers for Medicaid & Medicare Services from 2004 to 2006, to its board of directors. At least Former FDA commissioner David Kessler understands what conflict of interest means and testified against Johnson & Johnson and for the Risperdal victim at trial.
Some more have been settled.
I bet Schlomi is happy they left this market...
My favorite part of the article:
- J&J seeks in excess of $5 billion in damages and interest from Boston Scientific, a potentially massive judgment against a company that as of yesterday had a market capitalization of $17.8 billion
Call Gary Pruden. He can help.
You will be lucky to hit 100k total but you will have to negotiate to make that happen. The best advice I can give is go speciality. You don't want to be stuck in PC.
Johnson & Johnson has increased US pharmaceutical sales by over 30% over the last 12 months.
The company is seeing lackluster growth in the US in both its consumer division and medical devices and diagnostics.
Johnson & Johnson is not capitalizing on macro economic trends that are driving growth for competitors in emerging markets.
How sad that JNJ has come to this.
This is pretty sad. How about executives face jail time instead of paying a fine to get out of messing with someone's life.
"Unit ran amok marketing Pinnacle"
Good article. The FDA probably knew but only came clean because of the WSJ.
Interesting. What options would they have in cardiology or cardiothoracic surgery?
I think that is the goal. I heard JNJ also has an ownership in this therapy. Pretty smart if you ask me.